ReShape and Obalon Expect to Complete Merger After Market Close
ReShape and Obalon Expect to Complete Merger After Market Close
DJ ReShape and Obalon Expect to Complete Merger After Market Close
DJ Rehape和Obalon预计在收盘后完成合并
By Josh Beckerman
乔什·贝克曼(Josh Beckerman)著
ReShape Lifesciences Inc. and Obalon Therapeutics Inc., which focus on medical devices for weight loss, expect to complete their merger after the close of the market Tuesday.
专注于减肥医疗设备的重塑生命科学公司(Rehape Lifesciences Inc.)和奥巴隆治疗公司(Obalon Treateutics Inc.)预计将在周二市场收盘后完成合并。
Shares of Nasdaq-listed Obalon were recently up 7% to $3.47. OTCQB-listed ReShape was down 7% to $5.11.
在纳斯达克(Nasdaq)上市的Obalon股价最近上涨7%，至3.47美元。在OTCQB上市的Rehape股价下跌7%，至5.11美元。
The merged company's stock is expected to begin trading on the Nasdaq Capital Market Wednesday, under the ReShape name and symbol "RSLS."
合并后的公司股票预计将于周三在纳斯达克资本市场(Nasdaq Capital Market)开始交易，新的名称和代码为“RSLS”。
Write to Josh Beckerman at josh.beckerman@wsj.com
写信给乔什·贝克曼(Josh Beckerman)，电子邮件：josh.beckerman@wsj.com
(END) Dow Jones Newswires
(完)道琼通讯社
June 15, 2021 14:30 ET (18:30 GMT)
2021年6月15日东部时间14：30(格林尼治标准时间18：30)
Copyright (c) 2021 Dow Jones & Company, Inc.
版权所有(C)2021年道琼斯公司
